VentriPoint Diagnostics (TSE:VPT) has released an update.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Ventripoint Diagnostics has announced its plan to issue common shares to satisfy interest payments on its convertible debentures, pending approval from the TSXV. Additionally, the company has revised the terms of its convertible debenture offering, adjusting conversion rates over the term’s duration.
For further insights into TSE:VPT stock, check out TipRanks’ Stock Analysis page.
Trending Articles
- C3.ai Stock Wins a New Street-High Price Target
- ‘A Strong Year Is Coming,’ Says Top Analyst About AMD Stock
- ‘It’s Not Too Late to Load Up,’ Says Lance Vitanza About MicroStrategy Stock
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
